CorMedix Inc.
CRMD
$6.38
$0.010.16%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 163.06M | 162.50M | 51.16M | 17.18M | -17.93M |
| Total Depreciation and Amortization | 14.55M | 4.25M | 536.10K | 450.10K | 310.00K |
| Total Amortization of Deferred Charges | 398.00K | -- | -- | -- | -- |
| Total Other Non-Cash Items | -10.22M | -48.22M | 8.89M | 7.48M | 6.41M |
| Change in Net Operating Assets | 7.27M | -43.56M | -30.12M | -38.68M | -39.41M |
| Cash from Operations | 175.05M | 74.97M | 30.46M | -13.57M | -50.62M |
| Capital Expenditure | -2.26M | -550.00K | -54.00K | -64.90K | -116.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -308.51M | -310.00M | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 2.34M | -1.48M | -14.34M | 12.16M | 21.35M |
| Cash from Investing | -308.43M | -312.03M | -14.39M | 12.09M | 21.23M |
| Total Debt Issued | 150.00M | 150.00M | -- | -- | -- |
| Total Debt Repaid | -188.00K | -49.20K | -- | -- | -- |
| Issuance of Common Stock | 96.55M | 103.27M | 116.01M | 33.72M | 26.61M |
| Repurchase of Common Stock | -1.99M | -1.78M | -1.32M | -1.21M | -290.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -5.92M | -282.40K | -- | -- | -- |
| Cash from Financing | 238.45M | 251.15M | 114.69M | 32.51M | 26.32M |
| Foreign Exchange rate Adjustments | 0.00 | -200.00 | -100.00 | -1.00K | -2.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 105.07M | 14.09M | 130.77M | 31.03M | -3.07M |